Related Experiment Video
Updated: Jul 9, 2026
09:36
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Saving the Tiniest Heinies From Diaper Dermatitis in High-Risk Neonates
Alyssa Railsback1, Kaci Karas2
1Baylor Scott & White - Hillcrest, Waco, TX, USA alyssa.railsback@BSWHealth.org lyssa_10@att.net.
Neonatal Network : NN
|July 7, 2026
Summary
Applying Cavilon No Sting Barrier to high-risk newborns in the NICU significantly reduced diaper dermatitis rates from 53% to 10%. This effective skin care intervention prevents skin breakdown in vulnerable infants.
Area of Science:
- Neonatal care
- Dermatology
- Evidence-based practice
Background:
- Diaper dermatitis affects a significant number of Neonatal Intensive Care Unit (NICU) patients.
- Effective skin care is crucial for preventing skin breakdown in infants.
Purpose of the Study:
- To evaluate the efficacy of Cavilon No Sting Barrier in preventing diaper dermatitis in high-risk newborns.
- To determine if regular application of Cavilon No Sting Barrier reduces the incidence of diaper dermatitis in a Level III NICU.
Main Methods:
- An evidence-based project utilizing a pre- and post-intervention design.
- Application of Cavilon No Sting Barrier every 72 hours to high-risk newborns.
- Inclusion criteria: newborns experiencing neonatal withdrawal or under observation for infections with existing skin redness.
Main Results:
- The incidence of diaper dermatitis decreased from 53% to below 10% after implementing the Cavilon No Sting Barrier protocol.
- Consistent application of the barrier cream proved effective in preventing diaper dermatitis in the target population.
Conclusions:
- Cavilon No Sting Barrier application every 72 hours is a recommended intervention for preventing diaper dermatitis in NICU patients.
- Routine skin care with Cavilon No Sting Barrier should be implemented for all admitted NICU patients.
